Global Over the Counter (OTC) & Diet Supplementary Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Over the Counter (OTC) & Diet Supplementary Market Research Report 2024
Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of disease.
According to Mr Accuracy reports’s new survey, global Over the Counter (OTC) & Diet Supplementary market is projected to reach US$ 207730 million in 2034, increasing from US$ 135920 million in 2024, with the CAGR of 5.8% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Over the Counter (OTC) & Diet Supplementary market research.
Key manufacturers engaged in the Over the Counter (OTC) & Diet Supplementary industry include Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer and Sun Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Over the Counter (OTC) & Diet Supplementary were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Over the Counter (OTC) & Diet Supplementary market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over the Counter (OTC) & Diet Supplementary market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan
Segment by Type
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Hospital
Clinic
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Over the Counter (OTC) & Diet Supplementary report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Over the Counter (OTC) & Diet Supplementary market is projected to reach US$ 207730 million in 2034, increasing from US$ 135920 million in 2024, with the CAGR of 5.8% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Over the Counter (OTC) & Diet Supplementary market research.
Key manufacturers engaged in the Over the Counter (OTC) & Diet Supplementary industry include Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer and Sun Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Over the Counter (OTC) & Diet Supplementary were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Over the Counter (OTC) & Diet Supplementary market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over the Counter (OTC) & Diet Supplementary market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan
Segment by Type
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Over the Counter (OTC) & Diet Supplementary report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
